Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of RCKT will rise by +3.87% over the next 2 Weeks and hit $3.78 by Tuesday, February 3, 2026. In that time frame, RCKT's share price is expected to range between $3.64 and $3.92.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Feb 3, 2026 | 3.64 | 3.78 | 3.92 |
| Feb 2, 2026 | 3.65 | 3.80 | 3.95 |
| Jan 30, 2026 | 3.62 | 3.76 | 3.90 |
| Jan 29, 2026 | 3.74 | 3.88 | 4.02 |
| Jan 28, 2026 | 3.71 | 3.85 | 3.99 |
| Jan 27, 2026 | 3.56 | 3.71 | 3.84 |
| Jan 26, 2026 | 3.59 | 3.73 | 3.87 |
| Jan 23, 2026 | 3.55 | 3.69 | 3.84 |
| Jan 22, 2026 | 3.68 | 3.81 | 3.95 |
| Jan 21, 2026 | 3.65 | 3.78 | 3.92 |
RCKT shares rose +1.37% in Wednesday, January 21, 2026's trading session, rising from a previous close of $3.64 to move at $3.69. The stock demonstrated notable intraday movement (see RCKT's key stats for a full breakdown), fluctuating between $3.62 and $3.77, a +4.10% trading range. While recent weeks have seen some volatility, RCKT has managed to secure a +4.24% gain over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 1.94M shares changing hands, 1.06M fewer than the previous session. This amounted to $7.17M in total market activity.
Will RCKT Continue Its Upward Trend?
According to analyst ratings and projections for RCKT, Rocket Pharmaceuticals, Inc. shares are anticipated to increase by +5.98%, potentially reaching $3.92 per share by February 3, 2026. Short-term technical indicators currently suggest a neutral sentiment for RCKT. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 12 positive trading days within the past 30 sessions. Based on the RCKT stock forecast, now is a good time to buy RCKT stock because its current trading price is -2.40% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on RCKT covering social and institutional perspectives.
RCKT Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into RCKT's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 52.67% to 53.77%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 50.62%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 46.28%, maintains a neutral outlook for the long term. Insights into RCKT's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Rocket Pharmaceuticals Short-Term Forecasts
RCKT Forecast For Next 5 Days
Our algorithm anticipates Rocket Pharmaceuticals (RCKT) stock could hit $3.87 by Jan 28, 2026. This represents a +4.96% rise from today's price, following a +1.11% change over the past five days.
RCKT Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Rocket Pharmaceuticals, Inc. (RCKT) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $3.73, which would mean a +1.08% increase from the current price of $3.69. Projections for this period range from a high of $4.53 to a low of $3.00.
RCKT Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Rocket Pharmaceuticals's price over the next three months point to a rise. RCKT stock is expected to peak at $6.04 on Jan 21, 2026 before potentially dipping to $2.76 on Apr 20, 2026. On average, RCKT is likely to trade around $4.66 in the coming 90 days.
Rocket Pharmaceuticals Stock Forecast 2025
Based on our predictive models, Rocket Pharmaceuticals (RCKT) is expected to trade between $0.00 and $6.08 throughout 2026. This would result in an average price of $3.03, potentially offering investors a -17.89% return from current levels.
Rocket Pharmaceuticals, Inc. Monthly Forecast 2026–2027
January 2026
According to our latest forecast models, Rocket Pharmaceuticals, Inc. (RCKT) is positioned to show a strong performance in January 2026. The price is predicted to move between $5.03 and $6.08, settling at an average of $5.59. This could translate to a +51.49% gain.
February 2026
Based on current market signals, Rocket Pharmaceuticals, Inc. is projected to trend february 2026. We forecast a trading range from $4.34 to $5.60, with a likely average price of $4.92. Investors could expect a potential return of +33.33%.
March 2026
Our predictive algorithms indicate Rocket Pharmaceuticals, Inc. stock may see a shift in March 2026. The expected range spans $3.74–$5.51, with an average target of $4.74. This represents a positive outlook and a possible gain of +28.46%.
April 2026
Analyzing established trends, Rocket Pharmaceuticals, Inc. looks set to move in April 2026. Projections place the stock between $2.60 and $4.66, averaging around $3.59. This suggests a -2.71% loss from current levels.
May 2026
Market indicators suggest Rocket Pharmaceuticals, Inc. could experience notable changes during May 2026. Prices could fluctuate within $2.09 to $3.82, with a midpoint forecast of $3.25. The stock might deliver a -11.92% loss.
June 2026
Forecasting for June 2026, models estimate that Rocket Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $1.32 and $3.34, averaging $2.88. This signals a cautious trajectory with potential returns around -21.95%.
July 2026
According to our latest forecast models, Rocket Pharmaceuticals, Inc. (RCKT) is positioned to show a strong performance in July 2026. The price is predicted to move between $0.66 and $2.54, settling at an average of $2.35. This could translate to a -36.31% loss.
August 2026
Based on current market signals, Rocket Pharmaceuticals, Inc. is projected to trend august 2026. We forecast a trading range from $0.00 to $2.25, with a likely average price of $2.25. Investors could expect a potential return of -39.02%.
September 2026
Our predictive algorithms indicate Rocket Pharmaceuticals, Inc. stock may see a shift in September 2026. The expected range spans $0.00–$1.70, with an average target of $2.10. This represents a cautious outlook and a possible loss of -43.09%.
October 2026
Analyzing established trends, Rocket Pharmaceuticals, Inc. looks set to move in October 2026. Projections place the stock between $0.00 and $1.08, averaging around $1.99. This suggests a -46.07% loss from current levels.
November 2026
Market indicators suggest Rocket Pharmaceuticals, Inc. could experience notable changes during November 2026. Prices could fluctuate within $0.00 to $0.22, with a midpoint forecast of $2.12. The stock might deliver a -42.55% loss.
December 2026
Forecasting for December 2026, models estimate that Rocket Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.00, averaging $2.25. This signals a cautious trajectory with potential returns around -39.02%.
January 2027
According to our latest forecast models, Rocket Pharmaceuticals, Inc. (RCKT) is positioned to show a strong performance in January 2027. The price is predicted to move between $0.00 and $0.00, settling at an average of $2.37. This could translate to a -35.77% loss.
RCKT's history of dividends and stock splits also plays a role in long-term investor confidence.